Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × cediranib × Clear all

Phase

Phase 2 11 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

INDUSTRY 2 OTHER_GOV 1 OTHER 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Cisplatin 240 Radiotherapy 198 Fluorouracil 168 Cyclophosphamide 164 Capecitabine 161 Docetaxel 144 Oxaliplatin 136 Gemcitabine 133 Carboplatin 130 Paclitaxel 127 Dexamethasone 108 Drug Therapy 101 Leucovorin 99 Doxorubicin 99 Etoposide 82 Cytarabine 75 Bevacizumab 74 Vincristine 71 Irinotecan 64 Rituximab 63 Epirubicin 62 Methotrexate 54 Prednisone 53 Radiosurgery 52 Surgical Procedures, Operative 50 Radiotherapy, Intensity-Modulated 49 Radiation 49 Neoadjuvant Therapy 47 Lenalidomide 46 Chemotherapy, Adjuvant 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03278717 2022-09-27

ICON9

University College, London

Phase 3 Unknown

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡